Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Alzheimer's Disease

  Free Subscription


Articles published in Brain Res

Retrieve available abstracts of 58 articles:
HTML format
Text format



Single Articles


    April 2018
  1. LEE M, Ban JJ, Yang S, Im W, et al
    The exosome of adipose-derived stem cells reduces beta-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease.
    Brain Res. 2018 Apr 3. pii: S0006-8993(18)30177.
    PubMed     Text format     Abstract available


    February 2018
  2. MAJKUTEWICZ I, Kurowska E, Podlacha M, Myslinska D, et al
    Age-dependent effects of dimethyl fumarate on cognitive and neuropathological features in the streptozotocin-induced rat model of Alzheimer's disease.
    Brain Res. 2018 Feb 14. pii: S0006-8993(18)30080.
    PubMed     Text format     Abstract available


    January 2018
  3. GANNON M, Wang Q
    Complex Noradrenergic Dysfunction in Alzheimer's Disease: Low Norepinephrine Input is Not Always to Blame.
    Brain Res. 2018 Jan 4. pii: S0006-8993(18)30001.
    PubMed     Text format     Abstract available


  4. HUANG S, Tong H, Lei M, Zhou M, et al
    Astrocytic glutamatergic transporters are involved in Abeta-induced synaptic dysfunction.
    Brain Res. 2018;1678:129-137.
    PubMed     Text format     Abstract available


  5. MA Y, Ma B, Shang Y, Yin Q, et al
    Flavonoid-rich ethanol extract from the leaves of Diospyros kaki attenuates cognitive deficits, amyloid-beta production, oxidative stress, and neuroinflammation in APP/PS1 transgenic mice.
    Brain Res. 2018;1678:85-93.
    PubMed     Text format     Abstract available


  6. RIZZI L, Maria Portal M, Batista CEA, Missiaggia L, et al
    CSF Abeta1-42, but not p-Tau181, differentiates aMCI from SCI.
    Brain Res. 2018;1678:27-31.
    PubMed     Text format     Abstract available


    December 2017
  7. BRAUN D, Feinstein DL
    The locus coeruleus neuroprotective drug vindeburnol normalizes behavior in the 5xFAD transgenic mouse model of Alzheimer's disease.
    Brain Res. 2017 Dec 21. pii: S0006-8993(17)30563.
    PubMed     Text format     Abstract available


  8. SATOH A, Iijima KM
    Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging.
    Brain Res. 2017 Dec 21. pii: S0006-8993(17)30562.
    PubMed     Text format     Abstract available


    November 2017
  9. VOGELSANG P, Giil LM, Lund A, Vedeler CA, et al
    Reduced glucose transporter-1 in brain derived circulating endothelial cells in mild Alzheimer's disease patients.
    Brain Res. 2017 Nov 1. pii: S0006-8993(17)30493.
    PubMed     Text format     Abstract available


  10. PONNUSAMY R, McNerney W, Moghadam S, Salehi A, et al
    Assessing disease-modifying effects of norepinephrine in Down syndrome and Alzheimer's disease.
    Brain Res. 2017 Nov 1. pii: S0006-8993(17)30494.
    PubMed     Text format     Abstract available


    October 2017
  11. ZHAO Q, Lu H, Metmer H, Li WXY, et al
    Evaluating Functional Connectivity of Executive Control Network and Frontoparietal Network in Alzheimer's Disease.
    Brain Res. 2017 Oct 24. pii: S0006-8993(17)30483.
    PubMed     Text format     Abstract available


  12. LIU M, Jevtic S, Markham-Coultes K, Ellens NPK, et al
    Investigating the efficacy of a combination Abeta-targeted treatment in a mouse model of Alzheimer's disease.
    Brain Res. 2017 Oct 21. pii: S0006-8993(17)30473.
    PubMed     Text format     Abstract available


  13. CHIARAVALLOTI A, Barbagallo G, Ricci M, Martorana A, et al
    Brain metabolic correlates of CSF Tau protein in a large cohort of Alzheimer's disease patients: a CSF and FDG PET study.
    Brain Res. 2017 Oct 21. pii: S0006-8993(17)30474.
    PubMed     Text format     Abstract available


  14. TAI J, Liu W, Li Y, Li L, et al
    Neuroprotective effects of a Triple GLP-1/GIP/Glucagon receptor agonist in the APP/PS1 transgenic mouse model of Alzheimer's disease.
    Brain Res. 2017 Oct 16. pii: S0006-8993(17)30459.
    PubMed     Text format     Abstract available


  15. ZHAO J, Lu S, Yu H, Duan S, et al
    Baicalin and ginsenoside Rb1 promote the proliferation and differentiation of neural stem cells in Alzheimer's disease model rats.
    Brain Res. 2017 Oct 13. pii: S0006-8993(17)30443.
    PubMed     Text format     Abstract available


    September 2017
  16. REYES-MARIN KE, Nunez A
    Seizure susceptibility in the APP/PS1 mouse model of Alzheimer's disease and relationship with amyloid beta plaques.
    Brain Res. 2017 Sep 26. pii: S0006-8993(17)30423.
    PubMed     Text format     Abstract available


  17. JAGIRDAR R, Chin J
    Corticothalamic network dysfunction and Alzheimer's disease.
    Brain Res. 2017 Sep 14. pii: S0006-8993(17)30399.
    PubMed     Text format     Abstract available


    August 2017
  18. MENG Y, Ding L, Zhang HY, Yin WC, et al
    An Abeta3-10-KLH vaccine reduced Alzheimer's disease-like pathology and had a sustained effect in Tg-APPswe/PSEN1dE9 mice.
    Brain Res. 2017 Aug 2. pii: S0006-8993(17)30316.
    PubMed     Text format     Abstract available


    July 2017
  19. DEBAY DR, Reid GA, Macdonald IR, Mawko G, et al
    Butyrylcholinesterase-Knockout Reduces Fibrillar beta-amyloid and Conserves 18FDG Retention in 5XFAD Mouse Model of Alzheimer's Disease.
    Brain Res. 2017 Jul 17. pii: S0006-8993(17)30299.
    PubMed     Text format     Abstract available


    June 2017
  20. QU B, Gong Y, Gill JM, Kenney K, et al
    Heterozygous knockout of cytosolic phospholipase A2alpha attenuates Alzheimer's disease pathology in APP/PS1 transgenic mice.
    Brain Res. 2017 Jun 22. pii: S0006-8993(17)30269.
    PubMed     Text format     Abstract available


    May 2017
  21. FEI YL, Lv HJ, Li YB, Liu J, et al
    Tongxinluo improves cognition by decreasing beta-amyloid in spontaneous hypertensive rats.
    Brain Res. 2017;1663:151-160.
    PubMed     Text format     Abstract available


  22. LI LH, Tu QY, Deng XH, Xia J, et al
    Mutant presenilin2 promotes apoptosis through the p53/miR-34a axis in neuronal cells.
    Brain Res. 2017;1662:57-64.
    PubMed     Text format     Abstract available


    March 2017
  23. KLINGEBIEL M, Dinekov M, Kohler C
    Analysis of ribosomal protein S6 baseline phosphorylation and effect of tau pathology in the murine brain and human hippocampus.
    Brain Res. 2017;1659:121-135.
    PubMed     Text format     Abstract available


    February 2017
  24. LI L, Xue Z, Chen L, Chen X, et al
    Puerarin suppression of Abeta1-42-induced primary cortical neuron death is largely dependent on ERbeta.
    Brain Res. 2017;1657:87-94.
    PubMed     Text format     Abstract available


  25. LI L, Qin L, Lu HL, Li PJ, et al
    Methylene blue improves streptozotocin-induced memory deficit by restoring mitochondrial function in rats.
    Brain Res. 2017;1657:208-214.
    PubMed     Text format     Abstract available


  26. NAVIGATORE-FONZO L, Castro A, Pignataro V, Casais M, et al
    Daily rhythms of cognition-related factors are modified in an experimental model of alzheimer disease.
    Brain Res. 2017 Feb 2. pii: S0006-8993(17)30046.
    PubMed     Text format     Abstract available


    January 2017
  27. FANG X, Zhong X, Yu G, Shao S, et al
    Vascular protective effects of KLF2 on Abeta-induced toxicity: Implications for Alzheimer's disease.
    Brain Res. 2017 Jan 24. pii: S0006-8993(17)30006.
    PubMed     Text format     Abstract available


  28. HOSSEINI N, Alaei H, Reisi P, Radahmadi M, et al
    The effects of NBM- lesion on synaptic plasticity in rats.
    Brain Res. 2017;1655:122-127.
    PubMed     Text format     Abstract available


  29. JANG WY, Lee BR, Jeong J, Sung Y, et al
    Overexpression of serum amyloid a 1 induces depressive-like behavior in mice.
    Brain Res. 2017;1654.
    PubMed     Text format     Abstract available


    November 2016
  30. DUAN H, Jiang J, Xu J, Zhou H, et al
    Differences in Abeta brain networks in Alzheimer's disease and healthy controls.
    Brain Res. 2016 Nov 17. pii: S0006-8993(16)30775.
    PubMed     Text format     Abstract available


  31. TENTOLOURIS-PIPERAS V, Ryan NS, Thomas DL, Kinnunen KM, et al
    Brain imaging evidence of early involvement of subcortical regions in familial and sporadic Alzheimer's disease.
    Brain Res. 2016 Nov 12. pii: S0006-8993(16)30751.
    PubMed     Text format     Abstract available


    September 2016
  32. PADAYACHEE E, Zetterberg H, Portelius E, Boren J, et al
    Cerebrospinal fluid-induced retardation of amyloid beta aggregation correlates with Alzheimer's disease and the APOE epsilon4 allele.
    Brain Res. 2016 Sep 18. pii: S0006-8993(16)30651.
    PubMed     Text format     Abstract available


  33. ZHUANG S, Wang X, Wang HF, Li J, et al
    Angiotensin Converting Enzyme Serum Activities: Relationship with Alzheimer's disease.
    Brain Res. 2016 Sep 5. pii: S0006-8993(16)30611.
    PubMed     Text format     Abstract available


    July 2016
  34. PAPADANIIL CD, Kosmidou VE, Tsolaki A, Tsolaki M, et al
    Cognitive MMN and P300 in Mild Cognitive Impairment and Alzheimer's Disease: A High Density EEG-3D Vector Field Tomography Approach.
    Brain Res. 2016 Jul 30. pii: S0006-8993(16)30534.
    PubMed     Text format     Abstract available


    June 2016
  35. LEE JK, Wang K, Park MH, Kim N, et al
    Probing amyloid beta-induced cell death using a fluorescence-peptide conjugate in Alzheimer's disease mouse model.
    Brain Res. 2016 Jun 29. pii: S0006-8993(16)30465.
    PubMed     Text format     Abstract available


  36. YAN H, Zhu X, Xie J, Zhao Y, et al
    beta-amyloid increases neurocan expression through regulating Sox9 in astrocytes: a potential relationship between Sox9 and chondroitin sulfate proteoglycans in Alzheimer's disease.
    Brain Res. 2016 Jun 15. pii: S0006-8993(16)30434.
    PubMed     Text format     Abstract available


    May 2016
  37. SARKAR S, Jun S, Rellick S, Quintana DD, et al
    Expression of MicroRNA-34a in Alzheimer's Disease Brain Targets Genes Linked to Synaptic Plasticity, Energy Metabolism, and Resting State Network Activity.
    Brain Res. 2016 May 25. pii: S0006-8993(16)30382.
    PubMed     Text format     Abstract available


  38. DEIBEL SH, Weishaupt N, Regis AM, Hong NS, et al
    Subtle learning and memory impairment in an idiopathic rat model of Alzheimer's disease utilizing cholinergic depletions and beta-amyloid.
    Brain Res. 2016 May 18. pii: S0006-8993(16)30388.
    PubMed     Text format     Abstract available


    April 2016
  39. JAYANT S, Sharma BM, Sharma B
    Protective effect of transient receptor potential vanilloid subtype 1 (TRPV1) modulator, against behavioral, biochemical and structural damage in experimental models of Alzheimer's disease.
    Brain Res. 2016 Apr 12. pii: S0006-8993(16)30230.
    PubMed     Text format     Abstract available


  40. LI J, Liu CN, Wei N, Li XD, et al
    Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-beta peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's disease.
    Brain Res. 2016 Apr 9. pii: S0006-8993(16)30204.
    PubMed     Text format     Abstract available


    March 2016
  41. YOON SY, Kim DH
    Alzheimer's disease genes and autophagy.
    Brain Res. 2016 Mar 22. pii: S0006-8993(16)30147.
    PubMed     Text format     Abstract available


  42. WANG J, Li N, Ma J, Gu Z, et al
    Effects of an amyloid-beta 1-42 oligomers antibody screened from a phage display library in APP/PS1 transgenic mice.
    Brain Res. 2016;1635:169-79.
    PubMed     Text format     Abstract available


  43. PALLO SP, DiMaio J, Cook A, Nilsson B, et al
    Mechanisms of tau and Abeta-induced excitotoxicity.
    Brain Res. 2016;1634:119-31.
    PubMed     Text format     Abstract available


    February 2016
  44. HAYAMA T, Murakami K, Watanabe T, Maeda R, et al
    Single administration of a novel gamma-secretase modulator ameliorates cognitive dysfunction in aged C57BL/6J mice.
    Brain Res. 2016;1633:52-61.
    PubMed     Text format     Abstract available


  45. ZOU J, Wang M, Uchiumi O, Shui Y, et al
    Learning impairment by minimal cortical injury in a mouse model of Alzheimer's disease.
    Brain Res. 2016 Feb 11. pii: S0006-8993(16)30060.
    PubMed     Text format     Abstract available


    January 2016
  46. LIU C, Wu Y, Zha S, Liu M, et al
    Treatment effects of tanshinone IIA against intracerebroventricular streptozotocin induced memory deficits in mice.
    Brain Res. 2016;1631:137-46.
    PubMed     Text format     Abstract available


    December 2015
  47. MURAKAMI K, Watanabe T, Koike T, Kamata M, et al
    Pharmacological properties of a novel and potent gamma-secretase modulator as a therapeutic option for the treatment of Alzheimer's disease.
    Brain Res. 2015 Dec 17. pii: S0006-8993(15)00955.
    PubMed     Text format     Abstract available


    October 2015
  48. SULLIVAN SE, Young-Pearse T
    Induced pluripotent stem cells as a discovery tool for Alzheimer's disease.
    Brain Res. 2015 Oct 9. pii: S0006-8993(15)00742.
    PubMed     Text format     Abstract available


    September 2015
  49. SHETTY AK, Bates A
    Potential of GABA-ergic Cell Therapy for Schizophrenia, Neuropathic Pain, and Alzheimer's and Parkinson's Diseases.
    Brain Res. 2015 Sep 27. pii: S0006-8993(15)00717.
    PubMed     Text format     Abstract available


    August 2015
  50. DOTY KR, Guillot-Sestier MV, Town T
    The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
    Brain Res. 2015;1617:155-73.
    PubMed     Text format     Abstract available


  51. GREEN DL, Payne L, Polikar R, Moberg PJ, et al
    P50: A candidate ERP biomarker of prodromal Alzheimer's disease.
    Brain Res. 2015 Aug 6. pii: S0006-8993(15)00599.
    PubMed     Text format     Abstract available


    July 2015
  52. OLIVEIRA LT, Leon GV, Provance DW Jr, de Mello FG, et al
    Exogenous beta-amyloid peptide interferes with GLUT4 localization in neurons.
    Brain Res. 2015;1615:42-50.
    PubMed     Text format     Abstract available


  53. ZONG Y, Yu P, Cheng H, Wang H, et al
    miR-29c regulates NAV3 protein expression in a transgenic mouse model of Alzheimer's disease.
    Brain Res. 2015 Jul 23. pii: S0006-8993(15)00551.
    PubMed     Text format     Abstract available


  54. HOSONO T, Nishitsuji K, Nakamura T, Jung CG, et al
    Arachidonic acid diet attenuates brain Abeta deposition in Tg2576 mice.
    Brain Res. 2015;1613:92-9.
    PubMed     Text format     Abstract available


    June 2015
  55. ALTOBELLI GG, Cimini D, Esposito G, Iuvone T, et al
    Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection.
    Brain Res. 2015;1610:89-97.
    PubMed     Text format     Abstract available


  56. LI YP, Yang GJ, Jin L, Yang HM, et al
    Erythropoietin attenuates Alzheimer-like memory impairments and pathological changes induced by amyloid beta in mice.
    Brain Res. 2015 Jun 4. pii: S0006-8993(15)00447.
    PubMed     Text format     Abstract available


    May 2015
  57. JANOTA CS, Brites D, Lemere CA, Brito MA, et al
    Glio-vascular changes during ageing in wild-type and in Alzheimer's disease-like APP/PS1 mice.
    Brain Res. 2015 May 9. pii: S0006-8993(15)00370.
    PubMed     Text format     Abstract available


    January 2015
  58. CANDELA P, Saint-Pol J, Kuntz M, Boucau MC, et al
    In vitro discrimination of the role of LRP1 at the BBB cellular level: focus on brain capillary endothelial cells and brain pericytes.
    Brain Res. 2015;1594:15-26.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: